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Abstract
Chitinase is necessary for fungal growth and cell division and,
therefore, is an ideal target for the design of inhibitors which
may act as antifungal agents. A chitinase from the fungal
pathogen Coccidioides immitis has been expressed as a fusion
protein with gluathione-S-transferase (GST), which aids in
puri®cation. After cleavage from GST, chitinase was crystal-
lized from 30% PEG 4000 in 0.1 M sodium acetate pH 4.6. The
crystals have a tetragonal crystal lattice and belong to space
group P41212 or P43212 and diffract to 2.2 AÊ resolution. The
unit-cell parameters are a = b = 91.2, c = 95.4 AÊ ; there is only
one chitinase molecule in the asymmetric unit.
1. Introduction
The fungus Coccidioides immitis poses a major problem in
human pathogenesis. It is responsible for the life-threatening
lung infection coccidioidemycosis or San Joaquin Valley Fever
(Cole & Kirkland, 1991). Fungal infections can be particularly
dangerous in immunocompromized patients, such as those with
HIV infections. The severity of such fungal infections, parti-
cularly from Coccidioides, Candida, Cryptococcus and Histo-
plasmosis, has recently been extensively reviewed (Minamoto
& Rosenberg, 1997).
Fungal infections are usually dif®cult to treat because of the
lack of effective antifungal agents, and this has spurred a
search for enzymatic targets which may be suitable for the
design of antifungal agents. Fungi are eukaryotes, and many of
their enzymes are suf®ciently similar to human analogs that
drugs aimed at them will also adversely affect human tissue.
Identifying enzymes which are unique to fungi and necessary
for growth, therefore, allows the possible targeting of drugs
which would minimize effects on the recipients. One signi®cant
difference between fungi and mammals is that fungi contain a
cell wall, and enzymes responsible for cell-wall maintenance
qualify as possible candidates for drug design. The poly-
saccharide chitin is a major structural component in the cell
walls of many fungi, and chitin metabolism is required to
assure proper growth and cell division. The enzyme chitinase
catalyzes the hydrolysis of chitin, a -1,4-linked polymer of
N-acetylglucosamine, and has been shown to be necessary for
cell separation during the growth of Saccharomyces cerevisiae
(Kuranda & Robbins, 1991).
C. immitis contains two chitinases of 41 and 91 kDa called
CTS1 and CTS2, respectively (Pishko et al., 1995). The former
protein is the primary diagnostic complement ®xing antigen for
the fungus and a monoclonal antibody has been raised against
it (Johnson & Pappagianis, 1992; Dolan & Cox, 1991). As a
result, the chitinase has also been referred to as the CF/chit-
inase protein (Yang et al., 1996). The C. immitis chitinase shows
signi®cant amino-acid similarities to chitinases from other
fungi such as Aphanocladium album and Trichoderma
harzianum and from the bacteria Serratia marcescens (Pishko
et al., 1995). It has been suggested that this enzyme class plays a
role in remodeling fungal cell walls and in endospore release
(Johnson & Pappagianis, 1992). The structure of the C. immitis
protein will be important to our understanding of the
mechanism of this important class of enzymes and possibly to
the design of chitinase inhibitors which may act as fungal-
speci®c antibiotics.
Extracts of E. coli which had been transformed with the
GST-chitinase fusion plasmid yielded a single electrophoretic
band of 67 kDa when passed over a glutathione Sepharose
af®nity column. After cleavage with thrombin and adsorption
of GST on the column, a single band of 45 kDa was obtained.
The fusion and the cleaved protein had chitinase activity as
judged by the hydrolysis of 4-methylumbelliferyl
-N,N0,N0 0-triacetylchitotrioside.
Long thin rod-like crystals of the fusion protein at
20 mg mlÿ1 appeared in 12% PEG 20000, 0.1 M MES, pH 6.5,
0.1 M cadmium chloride. These crystals grew to almost 1 mm in
length, but never to more than 0.01 mm in diameter. Identical-
looking crystals of the chitinase alone appeared in 8% PEG
8000, 0.1 M Tris±HCl, pH 8.5. Diffraction experiments with
both crystal forms failed to show any detectable diffraction.
In an effort to improve crystal quality and diffraction,
screens of various molecular-weight PEGs were tried with
varying pH. After several weeks, small crystals of the chitinase
appeared in 30% PEG 4000, 0.1 M sodium acetate, pH 4.6. It
was found that these block-shaped crystals could be grown to
dimensions of 0.3 mm in less than a week by microseeding.
We collected 121441 observations of 20899 re¯ections. The
data were 99.7% complete to 2.2 AÊ with an overall Rmerge of
12%; Table 1 contains statistics for the data collection. Chit-
inase crystals show slight radiation sensitivity, deteriorating
after about 15 h in the X-ray beam. The crystal lattice belongs
to space group P41212 or P43212 and the unit-cell parameters
are a = b = 91.2, c = 95.4 AÊ . One molecule of chitinase per
asymmetric unit gives a reasonable volume-to-mass ratio, Vm
(Matthews, 1968), of 2.2 AÊ 3 Daÿ1, indicating that the crystals
contain about 42% solvent.
Soaking of the crystals with heavy metals proved unsuitable
because of crystal cracking or to large changes in the crystal
parameters. Chitinase which had been crystallized in the
presence of heavy metals, however, yielded usable crystals.
Harker sections of a difference Patterson map between the p-
hydroxymercuribenzoate (PHMB) derivative and native data
show self-consistent peaks for a single-site derivative. Re®ne-
ment of the metal position with MLPHARE from the CCP4
program suite (Collaborative Computational Project, Number
4, 1994) gave a ®gure of merit of 0.35. We plan to phase the
data either by a combination of SIR with the PHMB derivative
and molecular-replacement methods using the structure of a
related chitinase from Serratia marcescens (Perrakis et al.,
1994) as a search model or using molecular replacement alone
if the model is suf®cient.
2. Materials and methods
The gene for the 47 kDa chitinase from C. immitis was fused to
the C-terminal region of the gene for glutathione S-transferase
(Yang et al., 1996). During construction of the fusion the
amino-terminal 20 amino acids of chitinase were removed,
since they form a signal peptide which is normally cleaved
away during protein processing.
We transformed the fusion plasmid into E. coli and grew
0.5 l cultures to stationary phase. The cells were broken in a
French pressure cell (6.895  106 Pa), the debris was centri-
fuged out and the supernatant passed over a 3 ml glutathione
Sepharose af®nity column treated according to the manu-
facturers directions (Sigma, St Louis, MO, USA). About 30 mg
of fusion protein was obtained in a 20 ml volume. The ef¯uent
was concentrated to 2 ml, and a 10 thrombin-cleavage buffer
added (Novagen, Milwaukee, WI, USA). To remove GST from
the fusion protein, 15 units of thrombin were added and
allowed to react for 2 h at 288 K. After an overnight dialysis
against 6 mM phosphate and 300 mM NaCl at pH 7.3, the
mixture of cleaved proteins was again passed over the af®nity
column to remove GST and any remaining uncleaved fusion
protein. The resultant puri®ed chitinase, about 15 mg, was
dialyzed into 50 mM Tris buffer pH 7.5.
Chitinase activity was measured by monitoring the
production of methylumbelliferone product from the hydro-
lysis of 4-methylumbelliferyl -N,N0,N0 0-triacetylchitotrioside
(Hollis et al., 1997). Release of free methylumbelliferone was
measured by ¯uorescence spectrophotometry, using an
SLM 8000 ¯uorescence spectrophotometer, exciting at 360 nm
and measuring emission at 450 nm. A standard curve of free
methylumbelliferone was constructed and shown to be linear
over the range of product measured; this allowed the conver-
sion of ¯uorescence counts to nanomoles of methylumbelli-
ferone released per hour.
Crystallization trials were performed using both the GST-
chitinase fusion protein (20 mg mlÿ1) and the puri®ed chit-
inase (4 mg mlÿ1). Initial screening for crystals was performed
with Crystal Screen and Crystal Screen II (Hampton
Research) using the sitting-drop vapor-diffusion method.
Sitting drops contained equal volumes of protein solution and
precipitant solution from the well.
Heavy-metal soaks of methyl mercury, p-hydroxy-
mercuribenzoate (PHMB) and platinum tetrachloride were
performed by the addition of these compounds, dissolved in
well solution, to the drops containing crystals. Final metal
concentrations of 1, 2 and 5 mM were tried; the protein was
also crystallized in the presence of 2 mM of these compounds.
All diffraction experiments were performed in quartz
capillaries at room temperature. Diffraction data were
collected on these crystals to 2.2 AÊ resolution using an MSC
R-AXIS IV detector with a Rigaku RU200 rotating-anode
source with focusing mirrors. Data were collected by 20 min
exposures of 1.0 oscillations about the ’ axis. The diffraction
data were processed with the programs DENZO and
SCALEPACK (Otwinowski & Minor, 1997).
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Table 1. Statistics for crystallographic data from native chitinase
Resolution (AÊ ) 2.2
Rmerge (%) 12.2
Rmerge (last shell) (%) 21.3
|I/I| 10.3
|I/I| (last shell) 5.2
Completeness (%) 99.7
Completeness (I/I > 5) (%) 68.1
Completeness (I/I > 5) (last shell) (%) 43.1
Unique re¯ections 20899
Redundancy 6.0
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